ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
The Role of ICER as an Independent HTA
Learn why earlier monitoring of updates to ICER value frameworks and consideration of competitor and analog ICER assessments should be a priority.
Clinical Trial Solutions: Digital Technology Changing the Face of Clinical Trials
Investment in R&D is helping to accelerate growth in the CRO market and improving R&D efficiency by taking a holistic approach to trial transformation.
How RBM Is Changing The Role Of Monitors
How risk based monitoring is changing the role of monitors.
Challenges in Manufacturing and Distribution of CAR-T Therapies
ICON experts contribute to this Pharmafocus article on the challenges in the manufacturing and distribution of CAR-T therapies for patients.
Innovative CROs Support a More Integrated R&D Model
For the past decade, the pharma industry has been working to overcome what many called a “crisis” in R&D productivity.
Biomarkers in Oncology
ICON’s expert Mario Rocci talks to EBR about the use of biomarkers in oncology.
Challenges Faced in Patient Recruitment and Retention
The challenges faced in patient recruitment and retention in clinical trials in Pharma Focus Asia.
Disruptive innovation in the life science industry, based on a panel session hosted by ICON early in 2018 to gather views from senior executives from leading pharma
ELITE 2018 Transformational Leader
An article on Lee Termini's recognition as a ‘transformational leader’ and how he has brought value to market access and reimbursement.
Industry survey conducted by ICON in collaboration with ISR Research and Informa's Pharma Intelligence to examine the challenges facing pharma.